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1. INTRODUCTION 
We are studying the non-sequence-specific nucleic 
acid binding proteins of BaciNus stearothermophilus 
(Bst). During the course of purification of the DNA 
binding protein HU a major protein band was iden- 
tified on a cation exchange column just after the HU 
peak, with molecular weight of 17 kDa. Our interest in 
nucleic acids binding proteins led us to investigate this 
protein. The apparent molecular weight as well as the 
basic character of this protein initially suggested that it 
was the Bst homologue of the 17K DNA-binding pro- 
tein of E. co/i [1,2]. We therefore proceeded to study 
this protein in more detai.1. 
More recently, the determination of the first 25 N- 
terminal amino acid residues have shown that the pro- 
tein is in reality ribosomal protein L9 from the large 
subunit of the Bst ribosomes. The protein was original- 
ly given the number L17 from its position on 
2-dimensional electrophoresis gels [3] and its purifica- 
tion from Bst ribosomes and crystallisation were 
described [4]. At that time the sequence was shown not 
to be homologous to those of any of the E. co/i proteins 
for which a complete sequence was available. Since then 
no further studies on this protein have been published. 
The sequence has been shown to be homologous to that 
subsequently determined for E. coli L9 and we refer to 
the protein as L9 throughout his paper. 
During the past 20 years the procaryotic ribosome 
has been the subject of intensive study, To understand 
the function of the ribosomal machinery at the 
molecular level it is essential to gain a detailed informa- 
tion of the structure of its individual components0 A
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variety of different techniques have been applied, in- 
cluding: circular dichroism [5]; proton magnetic 
resonance [6]; microcalorimetry [7,8]; immune electron 
microscopy [9]; chemical cross-linking [lo]; fluores- 
cence spectroscopy [I 11; and reconstitution of ribo- 
somal subunits from their components [lZ]. These 
methods have provided the bulk of the information 
about the relative topology of the ribosomal proteins in 
’ the organelle. The E. co/i ribosomal proteins were 
studied first, and all 53 ribosomal proteins have been se- 
quenced. However, the E. coli ribosomal proteins have 
in general not produced good crystals for 
crystallographic studies, in spite of intensive fforts in 
a number of laboratories. 
The thermophilic bacterium Bst was early recognized 
as an excellent source of thermostable proteins. The 
fact that Bst proteins have been naturally selected to be 
stable at high temperature is reflected in a resistance to 
various denaturing conditions, and a resulting increase 
in the probability of crystallisation. This is particularly 
important for example with ribosomal proteins, which 
have been isolated from their normal environment in 
the cell where they probably rely on other proteins and 
rRNA for their stability. 
The crystallisation of a protein can be a time consum- 
ing process. Moreover the crystallisation trials require a 
significant amount of highly purified protein. 
Therefore we proceeded to clone and overexpress the 
L9 protein from ht. We used the in vitro gene 
amplification technique and cloned the bZ9 gene which 
encodes the protein. The E. coli BL2l(DE3) transfor- 
mant harbouring the b19 gene on the PET-3a plasmid 
was shown to overproduce the target gene at a very high 
level. The recombinant BC9 protein was subsequently 
purified and good quality stable crystals were obtained. 
Preliminary crystallographic data are presented. 
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2. EXPERIMENTAL PROCEDURES 
2.1. Moterio! 
The bacterial strains used are the E. coli KlZ strain HMS174 
(F-rwA r-ktzm+k&ifR) and the B strain BL21 (F-ompT 
r-am-a). The set of pET-3 expression vectors, as well as the host 
cells. were kindly provided by Dr F.W. Studier (Brookhaven National 
Laboratory, Upton, NY) [14,15]. 
The enzymes used for the cloning procedures and the pUC cloning 
system were from Boehringer Mannheim. The sequencing kit Se- 
quenasc was purchased from United States Biochemical (USB). The 
gene amplification kit was supplied by Perkin-Elmer (Cetus). The 
column chromatography media were from Pharmacia/LK& and all 
other chemicals were either from Sigma or from Merck, in the highest 
analytical grade, Synthetic oligonucleotides were prepared at the cen- 
tral EM&L DNA synthesis laboratory and purified by HPLC (Syn- 
chropak 300 Cts 6.5 pm, MZ Analysentechnik). 
2.2. In vitro amplification of the b19 gene from Bst total 
chromosomal DNA 
Total Bst chromosomal DNA was purified as described in [13]. In 
a typical 50 pi reaction the following components were mixed at the 
final concentration: Bst template DNA 20 ng/pl; primers #N, #C, 1 
PM of each; 2OOpM of each dNTP; Amplitaq DNA polymerase 0.025 
U/cl, in reaction buffer consisting of 10 mM Tris-HCI, pH 8.3 (at 
tS”C), SO mM KCI, 0.01% (w/v) gelatin, 0.5-4 mM total M&12. The 
gene amplification reaction was performed in the following steps per 
cycle: denaturation at 94°C for 1 min; annealing at 50°C for 1 min; 
and polymerization at 72°C for 2 min; for 30 cycles, using a Hybaid 
Biomctra device. One-tenth of the amplification mixture was normal- 
ly analyzed by 7C acrylamide/O. 18% bis-acrylamide gel elec- 
trophoresis in TBE buffer (45 mM Tris-borate, pH 8.0, 1 mM 
ethylenediamine tetra-acetic acid, EDTA) at 100-200 V constant 
voltage and stained with ethidium bromide. 
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2.3. Cloning of the b19 gene 
All further cloning procedures were carried out essentially as 
described in [13] or according to the manufacturers. The plasmids 
were purified using the Qiagen plasmid preparation kit (Diagen) and 
DNA fragments were extracted from agarose gels using the Mermaid 
kit from Dianova. 
In brief, the amplified bI9 gene was inserted into the Nindll 
linearized pUCl9 vector by blunt-end ligation. Four individual 
positive clones were sequenced (direct and reverse) using the chain ter- 
mination method [16]. The ca 470 bp &,??HI/iV&l DNA fragment, 
which contains the entire b19 gene, was directly cloned into the 
PET-3a vector (amp’ and unique BamHI,iV&l restriction sites) [IS], 
resulting in a pCVbl9 expression plasmid. The pCVbl9 plasmid was 
used to transform the BL21(DE3). The transformation was carried 
out with the CaClz method [l7], 
The BLZl(DE3) E. colicells, harbouring the pCVbl9 plasmid, were 
grown in LB medium overnight in the presence of 25 ag/ml am- 
picillin. Next day, the cells were diluted to a final ODheon,,, = 0.3 and 
the overexpression of the target gene was induced by adding 
isopropyl-P-D-thiogalactoside (IPTG) to 0.4 mM, final concentta- 
tion. At 0, I and 3 h after induction, samples were withdrawn and 
analyzed by the 12,5% sodium dodecylsulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) Laemmli system [IS] and stained with 
Coomassie blue G-250. 
2.4. Ovcre.wrcssiorr utrd mtrificntiot, of the BL9 nroteitr 
In P routine protein preparation a 2 lhre cell cuhure induced for 3 
h was used. The Induced bacteria were collected by low speed ten- 
trifugatlon atrd washed once with cold buffer W (50 mM Tris-HCI, 
pH 7.5, 100 mM NuCI, 0.1 mM pttct~ylmctt~ylsulpt~o~~yl fluoride, 
PMSF). Ail further procedures were earricd out at 0-4OC, oxeept 
where otherwise specified, The bacterial paste was rcsuapended in 5 
ml/p buffer A (1OmM Na~phasphatc, pH 7.0, I mM EDNA, 0.1 mM 
PMSf) canruining 0. I VQ (w/v) friten X-100. The cells were disrupted 
by sonication for 10 min. The total extract was clarified by centrifuga- 
tion in an SS34 rotor (Sorval) at 20000 rpm, for 20 min. The superna- 
tant was adjusted to 30% saturat.ion in ammonium sulfate. After 30 
min stirring, the non-precipitated material was separated by cen- 
trifugation as above. The soluble supernatant was diaiysed against 
buffer A overnight. The dialysed BL9 protein fraction was applied to 
a 20 ml CM-Sepharose CL-6B column. Bound proteins were eluted 
with a 400 ml NaCl (O-O.5 M) linear gradient. The collected fractions 
were analysed by 12.5% SDS-PAGE. The BL9 protein fractions were 
combined and diluted 1:2 with buffer B (10 mM Na-phosphate, pH 
6.0, 1 mM EDTA, 0.1 mM PMSF). The pH was adjusted to 6.0 and 
the protein solution was applied, portionwise, to a Mono-S FPLC 
column. The BL9 protein was eluted with a 200-250 mM NaCl linear 
short gradient. The final purification step gave very pure and concen- 
trated protein material ready for crystallisation. The protein concen- 
tration was determined by the Bradford method as described in [19]. 
2.5. Crystallisation 
Crystals of BL9 were grown by ‘hanging-drop’ vapor diffusion 
[to]. 10 mg/ml solution of BL9 protein was dialysed against 1.5 M 
ammonium sulfate, 50 mM sodium phosphate, pH 7.5. lOpI hanging 
drops of this solution were suspended above reservoirs containing 
1.75-2.0 M ammonium sulfate. Crystals appeared after I week at 
5°C. The conditions described are similar to those in [9]. We also used 
60-80% saturated sodium citrate, pH 6.4 as precipitant. 
3. RESULTS AND DISCUSSION 
3.1. Cloning and overexpression of the b 19 gene in 
E. coli 
The known primary structure of the BL9 protein [4] 
was used to design both primers in order to copy and 
amplify the corresponding gene from the total 
chromosomal DNA of Bacillus stearothermophilus. 
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Fig. I. Amplificalion of b/P target gene using the Taq polymerase 
rcnetion (PCK) from total chromo$omnl DNA of f?s/, Slots 1-8 car- 
rcspohd te0.5, 1.0, 1.5, 2.0, 2.5. 3.0, 3.5, 4,OmM touti Mg” in the 
reunion mixture. One-tenth of the reaction products was examined by 
7% PAGE ia TUE buffer and stained with ethldium bromide (for ex. 
wimcntal details set under methods). 
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l/l 31/11 
ATG AAG GTT ATT TTT TTA AAG GAT GTC AAA GGA AAA GGG AAA AM, GGG GAA ATC AAA AAT 
mt lys val ile phe leu lys asp val lys gly lys gly lys lys gly glu ile lys asn 
61/'21 91/31 
GTC GCC GAC GGC TAT GCC AAC AAC TTC TTA TTT AAA CAA GGG CTG GCC ATT GAA GCG ACG 
val ala asp gly tyr ala am aSn phe leu phe lys gin gly leu ala ile glu ala thr 
121/41 151/51 
CCA GCC AAT TTA AAA GCG CTC GAG GCG CAA AAA CAA AAA GAG CAG CGC CAG GCG GCC GAG 
pro ala asn leu lys ala leu glu ala gin 1~s gin lys glu gin arg gln ala ala glu 
181/61 211/71 
GAG CTG GCG AAT GCG AAA AAA TTG AAA GAA CAG CTT GAG AAG CTG ACA GTA ACC ATT CCA 
glu leu ala as" ala 1yS lye 1St1 lYS glu gin leu giU 1yS 1eU thr val thr ile pro 
241/81 271/91 
GCA AAG GCA GGC GAA GGC GGC CGT TTG TTC GGC TCG ATT ACG AGC AAG CAA ATC GCC GAG 
ala lys ala gly glu gly gly arg leu phe gly se= ile thr ser lys gin ile ala glu 
301/101 331/111 
TCG CTG CAA GCC CAA CAC CGC TTG AAG CTC GAC AAG CGC AAA ATT GAG CTT GCC GAT GCC 
ser leu gln ala gin his gly leu lys leu asp lys arg lys ile glu leu ala asp ala 
361/121 391/131 
ATT CGC GCG CTT GGA TAC ACG AAC GTG CCG GTG AAA CTC CRC CCA GAG GTA ACG GCG ACG 
ile arg ala leu gly tyr thr am val pro val lys leu his pro glu val thr ala thr 
421/141 
CTG AAA GTC CAT GTG ACC GAG CAG 
leu lys val his val thr glu gin 
Fig. 2. Nucleotide sequence and the deduced amino acid sequence of the b/9 gene amplified from the Bst total dhromosomal DNA and cloned in 
the PET-3a vector. 
The amplification reaction was carried out as above and pCVbl9 plasmid was used to transform the E. co/i 
the amplified gene was detected by gel electrophoresis. 
As shown in Fig. 1 the best amplification resuiis were 
BL%l(DE3) strain which is a lysogen bearing the T7 
found between 2.5 and 3 mM total Mg2+ in the reaction 
RNA polymerase gene on the host chromosome under 
mixture. The amount of the produced (copied and 
the control of the /acWVS promoter. The transformants 
were induced with IPTG for up to three hours. Fig. 3 
amplified) gene, as well as the specificity of the shows a 12.5% SDS-PAGE of the induction protein 
amplification product provided an excellent starting products. The overproduction of the BL9 protein is 
material for further cloning procedures. Both primers 
were designed to build an N&I restriction site at the 
clearly shown since this protein is about 20~25% of the 
5 ‘-end as well as a ESamHI site next after the stop codon 
total host protein. 
at the 3 ‘-end of the copied gene. The amplified gene 
was then introduced into the Hind11 site of the pUCI9 
plasmid by blunt-end ligation and verified by DNA se- 013013013M 
quencing. The sequence of the b19 gene and that deduc- 
ed by amino acid sequence of the protein are shown in 
Fig. 2. There are three differences from the primary 
structure of the BL9 protein determined by classical 
peptide sequencing [3]. The sequence Asn2’-Asn2*-Ser2’ 
in the gene sequence isAsn-Phe in the peptide sequence, 
i.e. one Asn is missing from the peptide sequence and 
the Ser is replaced by a Phe. The peptide sequence cor- 
responding to Glu60-G1u6’-Let:62 in the gene is Glu-Leu, 
i.e. one Glu is missing from the peptide sequence. Final- 
ly at the C-terminus of the protein we could not read the 
Lys residue, although is has been designed to be there 
on the 3’-primer. In order to avoid ambiguities from 
the amplification reaction we have cloned and sequenc- 
ed the b19 gene from two individual amplification reac- 
tions with identical results. 
The coding sequencing for the BL9 protein was in- 
troduced into the expression vector PET-3a deriving the 
pCVbf9 plasmid [15]. The PET-3a expression vector A B c 
has the N&I unique site located at the translation start 
site and therefore can direct the production of native 
I’ly. 3. 12.5% SDS-PACE of the total bacterinl proteins of the 
proteins. The expression vector contains a strong T7 
BL21(DE3) cell line hmbouring che pCVO/ 17 plasmid. 0, I, 3 itre the 
time intervals, in haura, after adding lPTG (0.4 mM final concentra- 
promoter, the T7 gene IO ribosome binding site and tp tion) to induct the overexpression of the bi9 target gene under the 
terminator (Tti) which may make the transcripts more control of the T7 RNA poiymcrase e, 10 prtimoter, A and 9 are two 
resistant to exonucleolytic degradation [ 141, The 
different individual clones expressing the 1119 target gene and CZ is the 
control (na target pm)~ 
206 
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Fig. 4. Crystals of BL9 sr o:ein obtained at 5°C over one week from I .75-2.0 M ammonium sulfate. The dimensions of the crystal are 2 mm x 
0.5 mm x 1.2 mm. (Bar length: 0.25 mm) 
3.2. Purification of the overexpressed IX.9 protein 
The extraction of the BL9 protein overproduced in E. 
co/i was made in a low ionic strength Tris buffer at 
neutral pH by physical disruption of the cells. An am- 
monium sulfate precipitation up to 30% was used to 
remove subcellular debris and gave a significant enrich- 
ment (40% of the total extractable proteins) in BL9 pro- 
tein. BL9 was further purified by cation-exchange col- 
umn chromatography on a CM-Sepharose CL-GB col- 
umn at pH 7.0. BL9 was bound to the CM column and 
eluted as a symmetrical peak between 170 and 240 mM 
NaCl, The first chromatographic step increased the 
purity of EL9 protein to about 90%. The final purifica- 
tion and simultaneous concentration step was made on 
a Mono-S FPLC column at pH 6.0. A routine prepara- 
tion of 5 g bacteria (2 litre culture) takes 2-3 days and 
gives at least 50 mg BL9. The BL9 protein is more than 
95% pure, and no other protein bands can be detected 
in a heavily overloaded acrylamide gel stained with 
Coomassie blue. 
ning at 2 kW. The space group and cell dimensions are 
shown in Table I, and are essentially identical to those 
reported for the non-cloned material 141. 
The crystals are quite stable in the X-ray beam. They 
diffract to at least 3.0 A and native data have been 
recorded to this resolution. A search for heavy-atom 
derivatives is in progress. We are working to introduce 
cysteine residues at several positions in the molecule by 
site-directed mutagenesis, to allow us to obtain mercury 
derivatives. The absence of sulfate ions in our 
crystallization buffer may well prove to be advan- 
tageous in the formation of heavy atom derivatives. 
Subsequent to our cloning and crystallisation of the 
BL9 protein a publication appeared presenting cloning 
of the S5, L6, L9 (i.e. BL9) and L18 from Bst and 
crystallisation of S5 [21], One amino acid difference 
was detected between our bi9 clone and those described 
in [21]; an extra Lys at the C-terminus of the protein 
was found. 
3.3. Crystallisatiort and data collection 
Initial crystallisation conditions were identical to 
those described in 141, However, recently we found that 
the use of 60-80%‘0 saturated sodium citrate pH 6,4, as 
precipitant significantly decreases the time for full 
crystal formation and gave an increased number of 
useful crystals, The crystals obtained were up to 2 mm 
long as shown in Fig. 4. The crystals have been 
characterised using an imaging plate scanner mounted 
on a cenvcntioml xaled-tube Scihrt X-ray murw run- 
Table I 
Propcrtirr of the UL9 ribosomrl protein crystals 
!37nce proup: P2,2,2 
Lnlticc ctlnslantl: a = 135.3 A 
b xl 37,s A 
c tl 48.9 A 
2Q7 
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Fig. 5. A 1” rotation image from a BL9 crystal. The data extend to about 3.0 A. 
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